Author:
Segal Sydney,Anyan Walter B.,Hill Reba M.,Kauffman Ralph E.,Mofenson Howard,Pruitt Albert W.,Shinefield Henry R.,Singer Harvey S.,Weinberger Miles M.,Brann Alfred W.,Hall Robert T.,Harper Rita G.,Little George A.,Maisels M. Jeffrey,McCracken George H.,Poland Ronald,Sunshine Philip,Whittinghill John A.,Mortimer Edward A.,Fulginiti Vincent A.,Brunell Philip A.,Calderon Ernesto,Cherry James D.,Ector Walton L.,Gershon Anne A.,Gotoff Samuel P.,Hughes Walter T.,Peter Georges
Abstract
The Center for Disease Control (CDC), after consultation with a panel of experts, has revised its recommendations for prevention of gonococcal ophthalmia neonatorum. These recommendations now state, "ophthalmic ointment or drops containing tetracycline or erythromycin or a 1% silver nitrate solution" are effective and acceptable.1-3 This is a change from previous recommendations which highlighted silver nitrate as the primary agent for prophylaxis.4 The American Academy of Pediatrics' committees support these recommendations.
The prevalence of largely asymptomatic genital gonococcal infection in pregnant women and the occurrence of gonococcal ophthalmia in untreated infants (estimated at 28%)5 born to infected women indicate the need for continued prophylaxis for all newborn infants.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology and Child Health
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献